FERRARA, PIETRO
 Distribuzione geografica
Continente #
AS - Asia 10.344
NA - Nord America 7.605
EU - Europa 5.088
SA - Sud America 1.265
AF - Africa 237
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 2
Totale 24.573
Nazione #
US - Stati Uniti d'America 7.171
VN - Vietnam 3.193
SG - Singapore 2.874
IT - Italia 1.915
CN - Cina 1.333
HK - Hong Kong 1.227
BR - Brasile 944
RU - Federazione Russa 799
DE - Germania 614
CA - Canada 319
IE - Irlanda 319
SE - Svezia 312
IN - India 300
BD - Bangladesh 291
ID - Indonesia 254
FR - Francia 220
GB - Regno Unito 218
FI - Finlandia 189
KR - Corea 163
AR - Argentina 110
NL - Olanda 107
IQ - Iraq 83
TR - Turchia 71
ZA - Sudafrica 71
ES - Italia 66
MX - Messico 63
PK - Pakistan 61
SA - Arabia Saudita 57
UA - Ucraina 56
IR - Iran 55
AT - Austria 54
JP - Giappone 54
EC - Ecuador 44
PL - Polonia 44
PH - Filippine 43
CH - Svizzera 39
MA - Marocco 39
MY - Malesia 39
TH - Thailandia 36
VE - Venezuela 36
CL - Cile 34
CO - Colombia 34
AU - Australia 30
UZ - Uzbekistan 27
KE - Kenya 25
PY - Paraguay 23
PE - Perù 21
AE - Emirati Arabi Uniti 20
AF - Afghanistan, Repubblica islamica di 19
TN - Tunisia 19
ET - Etiopia 18
JO - Giordania 17
NP - Nepal 17
EG - Egitto 16
PT - Portogallo 16
BE - Belgio 14
IL - Israele 14
OM - Oman 14
AL - Albania 13
CZ - Repubblica Ceca 13
DZ - Algeria 13
LT - Lituania 12
TW - Taiwan 12
JM - Giamaica 11
UY - Uruguay 11
GR - Grecia 10
KZ - Kazakistan 10
NG - Nigeria 9
RO - Romania 9
DO - Repubblica Dominicana 8
GT - Guatemala 8
SY - Repubblica araba siriana 7
BG - Bulgaria 6
BH - Bahrain 6
CR - Costa Rica 6
SK - Slovacchia (Repubblica Slovacca) 6
CI - Costa d'Avorio 5
HN - Honduras 5
LB - Libano 5
PS - Palestinian Territory 5
QA - Qatar 5
RS - Serbia 5
AZ - Azerbaigian 4
BO - Bolivia 4
HU - Ungheria 4
KG - Kirghizistan 4
KW - Kuwait 4
LK - Sri Lanka 4
NO - Norvegia 4
YE - Yemen 4
BY - Bielorussia 3
BZ - Belize 3
CD - Congo 3
DK - Danimarca 3
KH - Cambogia 3
LU - Lussemburgo 3
LY - Libia 3
MD - Moldavia 3
NI - Nicaragua 3
PA - Panama 3
Totale 24.523
Città #
Singapore 1.549
Hong Kong 1.190
Ho Chi Minh City 990
Hanoi 910
San Jose 773
Ashburn 746
Milan 550
Ann Arbor 468
Chandler 342
Frankfurt am Main 342
Hefei 320
Dublin 305
New York 268
Dallas 245
Los Angeles 242
Toronto 208
Chicago 207
Jakarta 195
Santa Clara 181
Fairfield 174
Seoul 154
Beijing 146
Rome 145
Council Bluffs 144
Helsinki 133
Seattle 123
Boardman 121
Da Nang 120
The Dalles 120
Princeton 115
Lauterbourg 114
São Paulo 112
Wilmington 101
Buffalo 92
Houston 88
Haiphong 83
Moscow 79
Woodbridge 70
Quận Bình Thạnh 66
Munich 60
Orem 60
Cambridge 56
Lawrence 56
Nuremberg 54
Altamura 52
Ha Long 50
London 50
Thái Nguyên 49
Biên Hòa 48
Lappeenranta 46
Ninh Bình 43
Vũng Tàu 42
San Diego 41
Can Tho 38
Hải Dương 38
Tokyo 38
Bologna 37
Rio de Janeiro 36
Bắc Ninh 32
Montreal 32
Brooklyn 31
Pune 31
Warsaw 31
Zurich 31
Phủ Lý 30
Quận Phú Nhuận 30
Turin 29
Atlanta 28
Denver 28
Dhaka 28
Naples 28
Salt Lake City 28
Columbus 27
Bắc Giang 26
Guangzhou 26
Quận Một 26
Riyadh 26
Shanghai 26
Baghdad 25
Johannesburg 25
Mexico City 25
Vienna 25
Chennai 23
Kent 23
Lấp Vò 23
New Delhi 23
San Francisco 23
Amsterdam 22
Phoenix 22
Bangkok 21
Florence 21
Tashkent 21
Washington 21
Nairobi 20
Poplar 20
Tampa 19
Brasília 18
Lang Son 18
Vĩnh Tường 18
Perugia 17
Totale 14.272
Nome #
Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 1.616
Should SARS-CoV-2 serological testing be used in the decision to deliver a COVID-19 vaccine booster? A pro-con assessment 630
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 579
Epidemiology of SLE in Italy: an observational study using a primary care database 554
Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 430
State of health and inequalities among Italian regions from 2000 to 2021: a systematic analysis based on the Global Burden of Disease Study 2021 412
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 394
Magnitude and time-course of excess mortality during COVID-19 outbreak: population-based empirical evidence from highly impacted provinces in northern Italy 371
Occupational exposure in the lombardy region (Italy) to sars-cov-2 infection: Results from the mustang–occupation–covid-19 study 357
Incidence and risk factors for falls among nursing home residents in Italy: a retrospective cohort study 346
Knowledge, Attitudes and Practices Survey of Recombinant Zoster Vaccine among Cardiologists and Cardiac Nurses in Italy 324
Analysis of hospital activity during the COVID-19 pandemic: population-based evidence from highly impacted provinces in northern Italy 302
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023 287
Estimates of the initial impact of the COVID-19 epidemic on overall mortality: evidence from Italy 284
Time-Trends in Air Pollution Impact on Health in Italy, 1990–2019: An Analysis From the Global Burden of Disease Study 2019 280
Azithromycin use and outcomes in patients with COVID-19: an observational real-world study 277
Changing life expectancy in European countries 1990–2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021 268
Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019 264
The economic impact of air pollution: a European assessment 253
Three decades of population health changes in Japan, 1990–2021: a subnational analysis for the Global Burden of Disease Study 2021 251
Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 244
Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 235
Azithromycin use and covid-19: a real-world observational study. 235
Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 235
Antidepressants Drug Use during COVID-19 Waves in the Tuscan General Population: An Interrupted Time-Series Analysis 225
Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019 219
Exploring different modelling approaches to forecast the community acute respiratory infections burden in children: an Italian epidemiological time series study 219
Cost and Cost Effectiveness of Treatments for Psoriatic Arthritis: An Updated Systematic Literature Review 217
A silent strain: the unseen burden of acute respiratory infections in children 215
Immunogenicity of Recombinant Zoster Vaccine: A Systematic Review, Meta-Analysis, and Meta-Regression 213
Statins Use in Patients with Cardiovascular Diseases and COVID-19 Outcomes: An Italian Population-Based Cohort Study 209
Cost-Effectiveness Analysis of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in Patients with Coronary and Peripheral Artery Diseases in Italy 207
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study 203
Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up 203
Humoral immunogenicity of primary yellow fever vaccination in infants and children: a systematic review, meta-analysis, and meta-regression 202
A vaginal birth is a cost-reduction strategy for women with a low-lying placenta 200
Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019 200
The economic impact of hypercholesterolemia and mixed dyslipidemia: A systematic review of cost of illness studies 200
Association between azithromycin use and clinical outcomes in COVID-19 patients: an Italian observational study 198
Estimates of cancer mortality attributable to carcinogenic infections in Italy 197
Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 193
Global Burden of Cardiovascular Diseases and Risks, 1990-2022 191
Knowledge about e-cigarettes and tobacco harm reduction among public health residents in europe 191
The use of test-negative case-control studies to determine the effectiveness of influenza vaccination in pregnancy: results from a systematic review and meta-analysis 188
Analisi della variazione del burden dell’inquinamento atmosferico in Italia dal 1990 al 2019: evidenze dai dati del Global Burden of Disease Study 185
Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021 185
Malaria prevention in the older traveller: A systematic review 185
The use of stand-by emergency treatment (SBET) for malaria in travellers: A systematic review and meta-analysis of observational studies 184
Valutazione dell’impatto della pandemia sugli accessi al sistema sanitario nei territori di Bergamo e Brescia 183
Valutazione della prognosi nei soggetti ospedalizzati con COVID-19 in relazione all’utilizzo pregresso di statine: uno studio osservazionale condotto nelle ATS di Bergamo e Brescia 179
Global injury morbidity and mortality from 1990 to 2017: Results from the Global Burden of Disease Study 2017 174
Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019 174
Pre-travel health care attendance among migrant travellers visiting friends and relatives (VFR): A 10-year retrospective analysis 171
Alcohol consumption in a sample of Italian healthcare workers: A cross-sectional study 169
Online information about risks and benefits of screening mammography in 10 European countries 167
Redistribution of garbage codes to underlying causes of death: a systematic analysis on Italy and a comparison with most populous Western European countries based on the Global Burden of Disease Study 2019 166
Awareness, attitudes, and practices toward meningococcal B vaccine among pediatricians in Italy 163
COVID-19 Vaccination and Public Health: Addressing Global, Regional, and Within-Country Inequalities 162
Estimating global injuries morbidity and mortality: Methods and data used in the Global Burden of Disease 2017 study 161
The burden of injury in Central, Eastern, and Western European sub-region: a systematic analysis from the Global Burden of Disease 2019 Study 161
Use of multidimensional item response theory methods for dementia prevalence prediction: an example using the Health and Retirement Survey and the Aging, Demographics, and Memory Study 159
Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019 159
Five insights from the Global Burden of Disease Study 2019 158
Respiratory Syncytial Virus (RSV) and Intention to Recommend RSV Vaccination: A Cross-Sectional Survey of Cardiologists and Cardiac Nurses in Southern Italy 155
Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019 153
Risk of Repeated Adverse Effects following Booster Dose of mRNA COVID-19 Vaccine: Results from the MOSAICO Study 147
Stime dell'antibiotico-resistenza in Italia e in Europa occidentale nel 2019: un'analisi comparativa basata su MICROBE [Estimates of antibiotic resistance in Italy and Western Europe in 2019: a MICROBE-based comparative analysis] 145
Smoking habits predict adverse effects after mRNA COVID-19 vaccine: Empirical evidence from a pilot study 145
Does smoking have an impact on the immunological response to COVID-19 vaccines? Evidence from the VASCO study and need for further studies 145
Microsporum nanum cutaneous infection in a traveller returning from Thailand: a diagnostic challenge 144
Stand-by emergency treatment (SBET) of malaria in Spanish travellers: A cohort study 144
Renal Resistive Index from Renal Hemodynamics to Cardiovascular Risk: Diagnostic, Prognostic, and Therapeutic Implications 143
Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1 141
COVID-19 and healthcare systems: What should we do next? 141
Renal Resistive Index and 10-Year Risk of Cardiovascular Disease Predicted by Framingham Risk Score and Pooled Cohort Equations: An Observational Study in Hypertensive Individuals Without Cardiovascular Disease 138
The adherence to guidelines for preventing CVC-related infections: A survey among Italian health-care workers 138
Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018 137
Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021 136
Seafarers' perceptions of job demand: A cross-sectional study 136
Relationship Between 8-iso-prostaglandin-F2α and Predicted 10-Year Cardiovascular Risk in Hypertensive Patients 134
Does age have an impact on acute mountain sickness? A systematic review 134
Health Risk Factors, Prevention, and Inequalities 133
Health Technology Assessment and Environmental Impact: A Scoping Review of State of Art and Future Perspective 133
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019 133
Trends and levels of the global, regional, and national burden of appendicitis between 1990 and 2021: findings from the Global Burden of Disease Study 2021 128
Global mortality from dementia: Application of a newmethod and results from the global burden of disease study 2019 128
Global, regional, and national burden of injuries, and burden attributable to injuries risk factors, 1990 to 2019: results from the Global Burden of Disease study 2019 127
Migrant health burden: Where do we stand? 127
The Temporal Correlation Between Positive Testing and Death in Italy: From the First Phase to the Later Evolution of the COVID-19 Pandemic 126
Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019 125
The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990–2019: a systematic analysis of the Global Burden of Disease Study 2019 124
A Systematic Review of Clinical Practice Guidelines for Caries Prevention following the AGREE II Checklist 124
Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up—Reply 121
Global, regional, and national burden of diseases and injuries for adults 70 years and older: Systematic analysis for the Global Burden of Disease 2019 Study 120
Assessing the economic burden of disease in migrants: The diabetes case in northern Italy 120
Analysis of the time evolution of covid-19 lethality during the first epidemic wave in Italy 120
The role of neurology in the development of community healthcare within the Italian national health service. The position of the Italian society of neurology (SIN) 120
Prevention, diagnosis and treatment of cervical cancer: A systematic review of the impact of COVID-19 on patient care 117
Dynamics of antibody response to BNT162b2 mRNA COVID-19 vaccine after 6 months 117
Burden of cancer mortality attributable to carcinogenic infections in Spain 116
Totale 21.678
Categoria #
all - tutte 83.473
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.473


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022776 78 54 78 65 73 32 79 55 48 24 85 105
2022/20231.473 115 369 151 133 98 219 36 96 126 29 53 48
2023/20241.742 60 89 82 132 159 354 234 78 153 64 126 211
2024/20256.462 223 471 166 238 351 340 289 163 515 688 566 2.452
2025/202613.630 2.192 1.046 908 1.233 1.270 663 1.707 521 982 1.109 759 1.240
2026/202747 47 0 0 0 0 0 0 0 0 0 0 0
Totale 25.067